Not Goofy: Mylan Partners with Disney

Mylan Inc, marketers of the Epipen® brand of epinephrine auto-injectors, have announced a multi-year strategic alliance with Disney Parks and Resorts to help increase awareness of anaphylaxis.

The agreement will facilitate the roll-out of stock epinephrine stations at Disney parks and cruise ships toward the end of 2014. Along with the roll-out, nurses and first aid personnel will receive training in the recognition of symptoms of anaphylaxis and the administration of epinephrine. Signage identifying nearby Epipen stations will be deployed as well.

Over time, the companies plan to introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.

We at applaud this agreement and all efforts – public and private – to disseminate stock epinephrine to all places of public accommodation. We believe epinephrine should be as accessible as AED defibrillators currently are, and that accompanying Good Samaritan laws should be in place to shield all responders who administer epinephrine in good faith.

Source: Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors
Print or share this article
Click to visit sponsor